김종성 (고려대학교/줄기세포연구소)님 | 한빛사연구자 > 한빛사

고려대학교/줄기세포연구소

최종업데이트 2024.07.23.

Antibody-Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
- Adv. Healthc. Mater., Apr 03 2024, | https://doi.org/10.1002/adhm.202400235
- 2024-04
- 바이오·의료융합
- 한빛사논문
INO80 exchanges H2A.Z for H2A by translocating on DNA proximal to histone dimers
- Nat. Commun., Published onlinedoi : 12 June 2017, 8, Article number: 15616 | 10.1038/ncomms15616
- 2017-06
- 한빛사논문
- 김종성(Harvard Medical School, Children’s Hospital Boston)
Force-induced on-rate switching and modulation by mutations in gain-of-function von Willebrand diseases
- Proc. Natl. Acad. Sci. USA, March 25, 2015 | doi: 10.1073/pnas.1501689112
- 2015-03
- 한빛사논문
- 김종성(Georgia Institute of Technology, 현 Harvard Medical School)
Bioresponsive Hydrogel Microlenses
- J. Am. Chem. Soc., 2005, 127 (26), pp 9588–9592 | DOI: 10.1021/ja0519076
- 2005-06
- 상위피인용논문
- 김종성(Harvard Medical School)
A mechanically stabilized receptor-ligand flex-bond important in the vasculature
- Nature, 466 ,992–995 (19 August 2010) | doi:10.1038/nature09295
- 2010-08
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문